The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats (Q28295236)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 8, 2010

Language	Label	Description	Also known as
English	The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats	scientific article published on October 8, 2010

Statements

scholarly article

0 references

The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: a microdialysis study in olfactory bulbectomized rats (English)

0 references

The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats (English)

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

animal disease model

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

7

object named as

S. M. Korte

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

author name string

J. Prins

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

K. G C. Westphal

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

G. A H. Korte-Bouws

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

M. S. Quinton

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

R. Schreiber

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

B. Olivier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

language of work or name

0 references

publication date

January 2011

0 references

8 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934452

30 July 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0091305710003187?httpAccept=text/xml

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

https://api.elsevier.com/content/article/PII:S0091305710003187?httpAccept=text/plain

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Pharmacology, Biochemistry and Behavior

0 references

97

0 references

3

0 references

444-52

0 references

Topographic distribution of dorsal and median raphe neurons with hippocampal, septal and dual projection

1

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

DOV 216,303, a "triple" reuptake inhibitor: safety, tolerability, and pharmacokinetic profile

2

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats

3

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects

4

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats

5

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

6

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

7

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Triple uptake inhibitors: therapeutic potential in depression and beyond

8

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Tolerance to therapeutic effects of antidepressants

9

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The role of dopamine in the mechanism of action of antidepressant drugs

10

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Antidepressant-induced liver injury

11

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression.

12

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The role of dopamine in the pathophysiology of depression

13

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

14

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The dopaminergic mesencephalic projections to the hippocampal formation in the rat.

15

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Effects of imipramine on the nocturnal behavior of bilateral olfactory bulbectomized rats

16

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

17

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors

18

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Pramipexole: augmentation in the treatment of depressive symptoms

19

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

20

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients

21

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression

22

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The olfactory bulbectomized rat as a model of depression: an update

23

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

24

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Exploratory behavior and spontaneous alternation in blind and anosmic rats

25

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex

26

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Neurocircuitry of addiction

27

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Blockade of corticosterone synthesis reduces serotonin turnover in the dorsal hippocampus of the rat as measured by microdialysis.

28

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease

29

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study

31

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors

32

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The role of the brain reward system in depression

33

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The mesolimbic dopamine reward circuit in depression

34

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.

35

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats

36

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Effects of bulbectomization, strain, and gentling on emotionality and exploratory behavior in rats

37

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

38

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats

39

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression

40

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The catecholamine hypothesis of affective disorders: a review of supporting evidence

41

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor

42

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor

43

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Evaluation of reward processes in an animal model of depression.

44

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Toxicity with selective serotonin reuptake inhibitors

45

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

The olfactory bulbectomised rat as a model of depression

46

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

47

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography

48

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study

49

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Dopamine and serotonin release in the nucleus accumbens during starvation-induced hyperactivity.

50

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

51

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Chronic mild stress-induced anhedonia: a realistic animal model of depression

52

1 reference

10.1016/J.PBB.2010.10.001

https://api.crossref.org/works/10.1016/J.PBB.2010.10.001

30 July 2024

Identifiers

10.1016/J.PBB.2010.10.001

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28295236&oldid=2216108018"